-
-
-
-
-
-
-
H.C. Wainwright on Compass Therapeutics (CMPX): 'we do believe the probability of a path forward is meaningfully higher than the market reaction observed'
-
-
-
-
-
-
-
Compass Therapeutics (CMPX) Reiterated at Buy by Stifel Ahead of April Disclosure
-
-
-
-
-
-
-
Craig-Hallum Starts Compass Therapeutics (CMPX) at Buy
-
-
-
-
-
-
-
William Blair Starts Compass Therapeutics (CMPX) at Outperform
-
-
-
-
-
-
-
Piper Sandler on Compass Therapeutics (CMPX): 'Early '8371 Responses Are Super Interesting'
-
-
-
-
-
-
-
Compass Therapeutics, Inc. (CMPX) Misses Q1 EPS by 1c
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)
-
414,410 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

